ストックスクリーナーアプリを入手
62.08
1.59%
-1.00
アフターアワーズ：
62.01
-0.07
-0.11%
Livanova Plc (LIVN) 最新ニュース
What risks investors should watch in LivaNova PLC stockWeekly Risk Summary & Daily Technical Stock Forecast Reports - Улправда
Is LivaNova PLC (LIA) stock prepared for digital transitionPrice Action & Daily Volume Surge Signals - Улправда
Why LivaNova PLC stock is popular among millennials2025 Sector Review & Long-Term Safe Investment Plans - Улправда
How LivaNova PLC (LIA) stock valuation compares with sectorWeekly Stock Summary & Pattern Based Trade Signal System - Улправда
Mizuho Maintains LivaNova (LIVN) Outperform Recommendation - Nasdaq
LivaNova (NASDAQ:LIVN) Price Target Raised to $72.00 - MarketBeat
LIVN Analyst Rating: Mizuho Raises Price Target to $72.00 | LIVN Stock News - GuruFocus
Nomura Holdings Inc. Takes $3.92 Million Position in LivaNova PLC $LIVN - MarketBeat
Assessing LivaNova (LIVN)’s Valuation After Hiring ResMed Veteran to Lead Sleep Apnea Commercialization - Sahm
Published on: 2025-12-15 17:44:51 - earlytimes.in
What drives LivaNova PLC stock priceEarnings Call Summaries & Real-Life Case Studies You Can Follow - earlytimes.in
LivaNova PLC (NASDAQ:LIVN) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
LivaNova’s Essenz Perfusion System, UK - Medical Device Network
LivaNova PLC $LIVN Holdings Reduced by Redmile Group LLC - MarketBeat
LivaNova stock hits 52-week high at 64.46 USD By Investing.com - Investing.com Australia
LivaNova to Present at Piper Sandler Healthcare Conference in December - MSN
LivaNova stock hits 52-week high at 64.46 USD - Investing.com
LivaNova (NASDAQ:LIVN) Hits New 52-Week HighHere's What Happened - MarketBeat
LivaNova (NASDAQ:LIVN) Reaches New 1-Year HighWhat's Next? - MarketBeat
Discipline and Rules-Based Execution in LIVN Response - news.stocktradersdaily.com
Working capital per share of LivaNova Plc – DUS:LIA - TradingView — Track All Markets
LivaNova price target raised to $63 from $61 at Baird - MSN
The Bull Case For LivaNova (LIVN) Could Change Following Medicare VNS Boost And New OSA Leader - simplywall.st
Marshall Wace LLP Has $36.68 Million Stake in LivaNova PLC $LIVN - MarketBeat
30,600 Shares in LivaNova PLC $LIVN Purchased by Quantbot Technologies LP - MarketBeat
New York State Common Retirement Fund Purchases 38,451 Shares of LivaNova PLC $LIVN - MarketBeat
LivaNova Appoints Lucile Blaise as Global Head of Commercialization, Obstructive Sleep Apnea - MSN
Improved Revenues Required Before LivaNova PLC (NASDAQ:LIVN) Stock's 26% Jump Looks Justified - simplywall.st
LivaNova PLC $LIVN Shares Sold by Kennedy Capital Management LLC - MarketBeat
Legal & General Group Plc Has $4.09 Million Stake in LivaNova PLC $LIVN - MarketBeat
LivaNova (NASDAQ:LIVN) Downgraded by Wall Street Zen to Buy - MarketBeat
LivaNova (LIVN): Assessing Valuation After CMS Boosts Reimbursement for VNS Therapy Procedures - Sahm
Why institutional investors increase stakes in LivaNova PLC (LIA) stockQuarterly Market Summary & Daily Stock Trend Watchlist - Newser
Prudential Financial Inc. Sells 71,065 Shares of LivaNova PLC $LIVN - MarketBeat
Will LivaNova PLC stock gain from strong economyWeekly Trade Recap & Verified Momentum Watchlists - Newser
How LivaNova PLC (LIA) stock reacts to fiscal policiesDividend Hike & Stepwise Trade Execution Plans - Newser
LivaNova to Highlight Real-World Evidence from CORE-VNS Study and New Health Economics Analyses at American Epilepsy Society 2025 Annual Meeting - facilitiesmanagement-now.com
LivaNova (Nasdaq: LIVN) to present CORE-VNS seizure and cost data at AES 2025 - Stock Titan
LivaNova appoints Lucile Blaise to lead sleep apnea commercialization By Investing.com - Investing.com Australia
LivaNova stock hits 52-week high at 64.1 USD - Investing.com India
LivaNova stock hits 52-week high at 64.1 USD By Investing.com - Investing.com South Africa
LivaNova PLC Appoints Lucile Blaise as Global Head of Commercialization, Obstructive Sleep Apnea, Effective December 1, 2025 - marketscreener.com
LivaNova appoints Lucile Blaise to lead sleep apnea commercialization - Investing.com
Livanova appoints Lucile Blaise as global head of commercialization, obstructive sleep apnea - marketscreener.com
LivaNova names Lucile Blaise global head of sleep apnea unit - StreetInsider
LivaNova PLC $LIVN Shares Acquired by Capital Fund Management S.A. - MarketBeat
Why LivaNova PLC (LIA) stock remains top ratedJuly 2025 Short Interest & Weekly Stock Performance Updates - Newser
Is LivaNova PLC (LIA) stock a buy before new product rolloutJuly 2025 Spike Watch & Long-Term Investment Growth Plans - Newser
Creative Planning Buys New Shares in LivaNova PLC $LIVN - MarketBeat
LivaNova (LIVN) Is Up 5.5% After Medicare Boosts VNS Therapy Reimbursement—Has the Bull Case Changed? - simplywall.st
1.14%
0.05%
大文字化:
|
ボリューム (24 時間):